ImmunoGen, Inc. (IMGN) Announces Webcast of its Investment Community Meeting on February 25, 2010
2/3/2010 10:15:47 AM
More...
|
ImmunoGen, Inc. (IMGN) Announces Webcast of Presentation at the 12th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/2/2010 10:34:25 AM
More...
|
ImmunoGen, Inc. (IMGN) Reports Second Quarter Fiscal Year 2010 Financial Results
1/29/2010 10:34:51 AM
More...
|
ImmunoGen, Inc. (IMGN) Announces Conference Call to Discuss Its Second Quarter Fiscal Year 2010 Financial Results
1/21/2010 10:17:26 AM
More...
|
ImmunoGen, Inc. (IMGN) Announces Webcast of Presentation at the 28th Annual J.P. Morgan Healthcare Conference
1/6/2010 9:34:24 AM
More...
|
ImmunoGen, Inc. (IMGN) Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality
12/18/2009 9:34:49 AM
More...
|
ImmunoGen, Inc. (IMGN) Announces Positive Trastuzumab-DM1 Clinical Data Reported at the San Antonio Breast Cancer Symposium
12/14/2009 9:37:42 AM
More...
|
ImmunoGen, Inc. (IMGN)'s SAR3419 Phase I Study Results in non-Hodgkin's Lymphoma at American Society of Hematology
12/8/2009 9:51:31 AM
More...
|
ImmunoGen, Inc. (IMGN) Announces Encouraging Clinical Data with Its IMGN901 Compound in the Treatment of Multiple Myeloma
12/7/2009 10:12:35 AM
More...
|
ImmunoGen, Inc. (IMGN) Announces Conference Call to Discuss Clinical Data Reported at Recent Medical Meetings
12/3/2009 12:43:51 PM
More...
|
|